Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 755 All time
- Disclosed funding
- $25.4B 617 disclosed amounts
- Median round
- $15.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| O OrebellaCompany profile Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail | Undisclosed | Series A | Healthtech, Consumer | United States | Investors | |
| GH Garner HealthCompany profile Helps patients choose healthcare providers using data and financial incentives. Helps patients choose healthcare providers using data and financial incentives. | $100M | Series ESeries C+ | Healthtech | United States | Investors | |
| KH Kubera HealthCompany profile Building the contract-to-payment system of record for American healthcare Building the contract-to-payment system of record for American healthcare | $6.5M | Seed | Healthtech | United States | Investors | |
| H H1Company profile Sells detailed information about doctors to pharma companies, hospital systems, and health insurers Sells detailed information about doctors to pharma companies, hospital systems, and health insurers | $40M | StrategicUndisclosed | Healthtech | United States | Investors | |
| CL Develops single-molecule PCR technology for genomics measurement | $26M | Series A | Healthtech, Biotech | United States | Investors | |
| T TriomicsCompany profile Building AI infrastructure to turn complex cancer records into structured intelligence Building AI infrastructure to turn complex cancer records into structured intelligence | $22M | Series B | Healthtech | United States | Investors | |
| S AI-native marketing agency accelerating pharma commercialization | $21M | Series A | Healthtech | United States | Investors | |
| P PsileraCompany profile Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions | $8.8M | Seed+Seed | Healthtech, Biotech | United States | Investors Undisclosed | |
| EL Ember LifeSciencesCompany profile Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution | $27M | Series A | Healthtech | United States | Investors | |
| ST Secretome TherapeuticsCompany profile Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy | $30M | Series A | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →